PRESS RELEASE published on 01/19/2026 at 07:30, 2 months 14 days ago Informations privilégiées / Autres communiqués Advicenne annonce l'acceptation de Sibnayal pour examen par la FDA aux Etats-Unis pour le traitement de l’ATRd. Date PDUFA fixée au 3 septembre 2026 FDA Advicenne ATRd Sibnayal PDUFA
PRESS RELEASE published on 01/19/2026 at 07:30, 2 months 14 days ago Inside Information / Other news releases FDA accepts Advicenne's Marketing Authorization Application for Sibnayal® for dRTA treatment in the US, with a PDUFA decision target date of September 3rd, 2026 FDA Advicenne Sibnayal DRTA PDUFA
BRIEF published on 01/12/2026 at 07:35, 2 months 21 days ago Renewal of the marketing authorization for Sibnayal® in the European Union Kidney Disease EMA Advicenna AMM Sibnayal®
BRIEF published on 01/12/2026 at 07:35, 2 months 21 days ago Renouvellement de l'AMM de Sibnayal® dans l'Union Européenne Advicenne Maladies Rénales EMA AMM Sibnayal®
PRESS RELEASE published on 01/12/2026 at 07:30, 2 months 21 days ago Informations privilégiées / Autres communiqués Advicenne annonce le succès du renouvellement de l’AMM de Sibnayal® dans l’Union Européenne. L'EMA a validé l'autorisation de mise sur le marché, renforçant le développement commercial de Sibnayal® Renouvellement Union Européenne Advicenne AMM Sibnayal
BRIEF published on 11/04/2025 at 11:35, 4 months 28 days ago Advicenne soumet Sibnayal® à la FDA américaine FDA Advicenne Sibnayal® Acidose Tubulaire Rénale Dépôt D'enregistrement
BRIEF published on 11/04/2025 at 11:35, 4 months 28 days ago Advicenne submits Sibnayal® to the US FDA FDA Advicenna Sibnayal® Renal Tubular Acidosis Registration Filing
PRESS RELEASE published on 11/04/2025 at 11:30, 4 months 28 days ago Informations privilégiées / Autres communiqués Advicenne dépose le dossier d'enregistrement de Sibnayal® auprès de la FDA américaine pour le traitement de l'ATRd. Webconférence le 5 novembre 2025. Informations sur ADV7103 et le développement clinique FDA Advicenne Webconférence ATRd Sibnayal
PRESS RELEASE published on 11/04/2025 at 11:30, 4 months 28 days ago Inside Information / Other news releases Advicenne submits registration application for Sibnayal® in dRTA treatment to US FDA, designated orphan drug. Evaluation process expected to take 12 months Advicenne Sibnayal® US FDA DRTA Treatment Registration Application
BRIEF published on 09/19/2025 at 18:05, 6 months 13 days ago Advicenne : Résultats semestriels en 2025 et perspectives Chiffre D'affaires Résultats Financiers Perspectives États-Unis Sibnayal®
Published on 04/02/2026 at 22:00, 8 hours 39 minutes ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 12 hours 7 minutes ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 15 hours 39 minutes ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 15 hours 59 minutes ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 16 hours 9 minutes ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/02/2026 at 23:55, 6 hours 44 minutes ago Brazil's second-crop corn can provide a low-carbon pathway for Sustainable Aviation Fuel (SAF)
Published on 04/02/2026 at 23:05, 7 hours 34 minutes ago DeFi Technologies Announces Audited Full Year 2025 Financial Results with Record Revenue of $99.1 Million and Record Net Income of $62.7 Million
Published on 04/02/2026 at 21:43, 8 hours 56 minutes ago EQS-Adhoc: EPH Group AG: Agreement on the Acquisition of a Resort Project in Vorarlberg
Published on 04/02/2026 at 19:52, 10 hours 47 minutes ago E-PANGO: Composition du capital au 31 mars 2026
Published on 04/02/2026 at 18:39, 12 hours ago Mersen : Déclaration des transactions sur actions propres
Published on 04/02/2026 at 18:30, 12 hours 9 minutes ago Thales met à disposition son Document d’Enregistrement Universel 2025
Published on 04/02/2026 at 18:30, 12 hours 9 minutes ago Thales makes available its Universal Registration Document 2025
Published on 04/02/2026 at 18:22, 12 hours 17 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Mars 2026
